nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—BCHE—Irinotecan—lung cancer	0.0734	0.551	CbGbCtD
Succinylcholine—BCHE—Cisplatin—lung cancer	0.0598	0.449	CbGbCtD
Succinylcholine—CHRND—pericardium—lung cancer	0.0491	0.377	CbGeAlD
Succinylcholine—BCHE—diaphragm—lung cancer	0.0225	0.173	CbGeAlD
Succinylcholine—CHRND—respiratory system—lung cancer	0.00935	0.0718	CbGeAlD
Succinylcholine—CHRNG—trachea—lung cancer	0.00871	0.0669	CbGeAlD
Succinylcholine—CHRNG—bone marrow—lung cancer	0.00691	0.0531	CbGeAlD
Succinylcholine—CHRNG—lung—lung cancer	0.00626	0.0481	CbGeAlD
Succinylcholine—Respiratory failure—Crizotinib—lung cancer	0.00583	0.0244	CcSEcCtD
Succinylcholine—Respiratory failure—Pemetrexed—lung cancer	0.00533	0.0223	CcSEcCtD
Succinylcholine—Respiratory failure—Gefitinib—lung cancer	0.0053	0.0222	CcSEcCtD
Succinylcholine—CHRND—lung—lung cancer	0.00497	0.0381	CbGeAlD
Succinylcholine—Renal failure acute—Pemetrexed—lung cancer	0.00411	0.0172	CcSEcCtD
Succinylcholine—CHRNA10—lymph node—lung cancer	0.00363	0.0279	CbGeAlD
Succinylcholine—Rhabdomyolysis—Erlotinib—lung cancer	0.00351	0.0147	CcSEcCtD
Succinylcholine—Respiratory failure—Topotecan—lung cancer	0.0032	0.0134	CcSEcCtD
Succinylcholine—Bradycardia—Crizotinib—lung cancer	0.00293	0.0123	CcSEcCtD
Succinylcholine—Renal failure—Pemetrexed—lung cancer	0.00288	0.012	CcSEcCtD
Succinylcholine—Respiratory failure—Vinorelbine—lung cancer	0.00274	0.0115	CcSEcCtD
Succinylcholine—Bronchospasm—Teniposide—lung cancer	0.00262	0.0109	CcSEcCtD
Succinylcholine—CHRM1—trachea—lung cancer	0.0026	0.02	CbGeAlD
Succinylcholine—Arrhythmia—Crizotinib—lung cancer	0.00257	0.0107	CcSEcCtD
Succinylcholine—BCHE—respiratory system—lung cancer	0.00257	0.0197	CbGeAlD
Succinylcholine—Renal failure acute—Erlotinib—lung cancer	0.00244	0.0102	CcSEcCtD
Succinylcholine—Pulmonary oedema—Vinorelbine—lung cancer	0.00239	0.01	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Topotecan—lung cancer	0.00236	0.00986	CcSEcCtD
Succinylcholine—Arrhythmia—Pemetrexed—lung cancer	0.00235	0.00982	CcSEcCtD
Succinylcholine—Arrhythmia—Gefitinib—lung cancer	0.00233	0.00976	CcSEcCtD
Succinylcholine—Respiratory failure—Gemcitabine—lung cancer	0.0022	0.0092	CcSEcCtD
Succinylcholine—CHRNB1—lymph node—lung cancer	0.00219	0.0168	CbGeAlD
Succinylcholine—Apnoea—Etoposide—lung cancer	0.00218	0.0091	CcSEcCtD
Succinylcholine—Cardiac arrest—Topotecan—lung cancer	0.00217	0.00907	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Irinotecan—lung cancer	0.00215	0.00901	CcSEcCtD
Succinylcholine—BCHE—bronchus—lung cancer	0.00211	0.0162	CbGeAlD
Succinylcholine—Shock—Crizotinib—lung cancer	0.00201	0.00841	CcSEcCtD
Succinylcholine—Hyperkalaemia—Cisplatin—lung cancer	0.00198	0.00827	CcSEcCtD
Succinylcholine—Flushing—Teniposide—lung cancer	0.00198	0.00827	CcSEcCtD
Succinylcholine—Hypertension—Pemetrexed—lung cancer	0.00198	0.00827	CcSEcCtD
Succinylcholine—Myalgia—Pemetrexed—lung cancer	0.00195	0.00815	CcSEcCtD
Succinylcholine—Pulmonary oedema—Gemcitabine—lung cancer	0.00192	0.00804	CcSEcCtD
Succinylcholine—Arrhythmia—Teniposide—lung cancer	0.0019	0.00796	CcSEcCtD
Succinylcholine—BCHE—trachea—lung cancer	0.0019	0.0146	CbGeAlD
Succinylcholine—Anaphylactic shock—Pemetrexed—lung cancer	0.00187	0.00781	CcSEcCtD
Succinylcholine—CHRM1—lung—lung cancer	0.00187	0.0143	CbGeAlD
Succinylcholine—Respiratory failure—Paclitaxel—lung cancer	0.00184	0.0077	CcSEcCtD
Succinylcholine—Shock—Pemetrexed—lung cancer	0.00184	0.00769	CcSEcCtD
Succinylcholine—Shock—Gefitinib—lung cancer	0.00183	0.00764	CcSEcCtD
Succinylcholine—BCHE—cardiac atrium—lung cancer	0.00178	0.0137	CbGeAlD
Succinylcholine—Renal failure acute—Irinotecan—lung cancer	0.00174	0.00729	CcSEcCtD
Succinylcholine—Hypotension—Gefitinib—lung cancer	0.00173	0.00725	CcSEcCtD
Succinylcholine—Renal failure—Erlotinib—lung cancer	0.00171	0.00715	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Pemetrexed—lung cancer	0.0017	0.00712	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Irinotecan—lung cancer	0.00166	0.00696	CcSEcCtD
Succinylcholine—Bronchospasm—Vinorelbine—lung cancer	0.00166	0.00694	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Gemcitabine—lung cancer	0.00162	0.00678	CcSEcCtD
Succinylcholine—Body temperature increased—Crizotinib—lung cancer	0.00162	0.00676	CcSEcCtD
Succinylcholine—Hypertension—Teniposide—lung cancer	0.0016	0.00669	CcSEcCtD
Succinylcholine—Hypertonia—Paclitaxel—lung cancer	0.00158	0.00663	CcSEcCtD
Succinylcholine—Renal failure acute—Cisplatin—lung cancer	0.00158	0.00662	CcSEcCtD
Succinylcholine—Respiratory failure—Docetaxel—lung cancer	0.00156	0.00653	CcSEcCtD
Succinylcholine—Cardiac arrest—Irinotecan—lung cancer	0.00153	0.0064	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Cisplatin—lung cancer	0.00151	0.00632	CcSEcCtD
Succinylcholine—BCHE—bone marrow—lung cancer	0.00151	0.0116	CbGeAlD
Succinylcholine—Urticaria—Pemetrexed—lung cancer	0.00148	0.00621	CcSEcCtD
Succinylcholine—Tachycardia—Teniposide—lung cancer	0.00148	0.00618	CcSEcCtD
Succinylcholine—Body temperature increased—Pemetrexed—lung cancer	0.00148	0.00618	CcSEcCtD
Succinylcholine—Urticaria—Gefitinib—lung cancer	0.00147	0.00617	CcSEcCtD
Succinylcholine—Body temperature increased—Gefitinib—lung cancer	0.00147	0.00614	CcSEcCtD
Succinylcholine—Renal failure acute—Paclitaxel—lung cancer	0.00142	0.00595	CcSEcCtD
Succinylcholine—Hypotension—Teniposide—lung cancer	0.00141	0.00591	CcSEcCtD
Succinylcholine—Arrhythmia—Erlotinib—lung cancer	0.00139	0.00584	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Etoposide—lung cancer	0.00138	0.00579	CcSEcCtD
Succinylcholine—Hypersensitivity—Pemetrexed—lung cancer	0.00138	0.00576	CcSEcCtD
Succinylcholine—Hypersensitivity—Gefitinib—lung cancer	0.00137	0.00572	CcSEcCtD
Succinylcholine—Pulmonary oedema—Docetaxel—lung cancer	0.00136	0.00571	CcSEcCtD
Succinylcholine—BCHE—lung—lung cancer	0.00136	0.0105	CbGeAlD
Succinylcholine—Bronchospasm—Gemcitabine—lung cancer	0.00133	0.00558	CcSEcCtD
Succinylcholine—Apnoea—Methotrexate—lung cancer	0.0013	0.00545	CcSEcCtD
Succinylcholine—Rash—Crizotinib—lung cancer	0.00129	0.00539	CcSEcCtD
Succinylcholine—Dermatitis—Crizotinib—lung cancer	0.00129	0.00539	CcSEcCtD
Succinylcholine—Cardiac arrest—Etoposide—lung cancer	0.00127	0.00533	CcSEcCtD
Succinylcholine—Flushing—Vinorelbine—lung cancer	0.00125	0.00524	CcSEcCtD
Succinylcholine—Cardiac arrest—Paclitaxel—lung cancer	0.00125	0.00522	CcSEcCtD
Succinylcholine—Hypertension—Vinblastine—lung cancer	0.00122	0.00511	CcSEcCtD
Succinylcholine—Renal failure—Irinotecan—lung cancer	0.00122	0.0051	CcSEcCtD
Succinylcholine—Arrhythmia—Vinorelbine—lung cancer	0.00121	0.00505	CcSEcCtD
Succinylcholine—Urticaria—Teniposide—lung cancer	0.0012	0.00503	CcSEcCtD
Succinylcholine—Body temperature increased—Teniposide—lung cancer	0.0012	0.005	CcSEcCtD
Succinylcholine—Renal failure—Gemcitabine—lung cancer	0.00119	0.00497	CcSEcCtD
Succinylcholine—Rash—Pemetrexed—lung cancer	0.00118	0.00493	CcSEcCtD
Succinylcholine—Dermatitis—Pemetrexed—lung cancer	0.00118	0.00492	CcSEcCtD
Succinylcholine—Rash—Gefitinib—lung cancer	0.00117	0.00489	CcSEcCtD
Succinylcholine—Myalgia—Topotecan—lung cancer	0.00117	0.00489	CcSEcCtD
Succinylcholine—Dermatitis—Gefitinib—lung cancer	0.00117	0.00489	CcSEcCtD
Succinylcholine—Myalgia—Erlotinib—lung cancer	0.00116	0.00484	CcSEcCtD
Succinylcholine—Bronchospasm—Etoposide—lung cancer	0.00114	0.00476	CcSEcCtD
Succinylcholine—Bradycardia—Irinotecan—lung cancer	0.00113	0.00474	CcSEcCtD
Succinylcholine—Respiratory failure—Methotrexate—lung cancer	0.00112	0.00471	CcSEcCtD
Succinylcholine—Anaphylactic shock—Topotecan—lung cancer	0.00112	0.00469	CcSEcCtD
Succinylcholine—Hypersensitivity—Teniposide—lung cancer	0.00111	0.00466	CcSEcCtD
Succinylcholine—Renal failure—Cisplatin—lung cancer	0.00111	0.00463	CcSEcCtD
Succinylcholine—Shock—Erlotinib—lung cancer	0.00109	0.00457	CcSEcCtD
Succinylcholine—Flushing—Irinotecan—lung cancer	0.00103	0.00432	CcSEcCtD
Succinylcholine—Bradycardia—Cisplatin—lung cancer	0.00103	0.00431	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Topotecan—lung cancer	0.00102	0.00427	CcSEcCtD
Succinylcholine—Hypertension—Vinorelbine—lung cancer	0.00101	0.00424	CcSEcCtD
Succinylcholine—Renal failure—Etoposide—lung cancer	0.00101	0.00424	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00101	0.00423	CcSEcCtD
Succinylcholine—Myalgia—Vinorelbine—lung cancer	0.001	0.00419	CcSEcCtD
Succinylcholine—Arrhythmia—Irinotecan—lung cancer	0.000994	0.00416	CcSEcCtD
Succinylcholine—Renal failure—Paclitaxel—lung cancer	0.000994	0.00416	CcSEcCtD
Succinylcholine—Pulmonary oedema—Methotrexate—lung cancer	0.000983	0.00411	CcSEcCtD
Succinylcholine—Arrhythmia—Gemcitabine—lung cancer	0.000969	0.00405	CcSEcCtD
Succinylcholine—Anaphylactic shock—Vinorelbine—lung cancer	0.000959	0.00401	CcSEcCtD
Succinylcholine—Rash—Teniposide—lung cancer	0.000954	0.00399	CcSEcCtD
Succinylcholine—Dermatitis—Teniposide—lung cancer	0.000953	0.00399	CcSEcCtD
Succinylcholine—Bronchospasm—Docetaxel—lung cancer	0.000946	0.00396	CcSEcCtD
Succinylcholine—Hyperkalaemia—Doxorubicin—lung cancer	0.00094	0.00393	CcSEcCtD
Succinylcholine—Flushing—Cisplatin—lung cancer	0.000938	0.00392	CcSEcCtD
Succinylcholine—Tachycardia—Vinorelbine—lung cancer	0.000936	0.00392	CcSEcCtD
Succinylcholine—BCHE—lymph node—lung cancer	0.000933	0.00716	CbGeAlD
Succinylcholine—Salivary hypersecretion—Doxorubicin—lung cancer	0.000929	0.00389	CcSEcCtD
Succinylcholine—Bradycardia—Paclitaxel—lung cancer	0.000924	0.00387	CcSEcCtD
Succinylcholine—Arrhythmia—Cisplatin—lung cancer	0.000903	0.00378	CcSEcCtD
Succinylcholine—Hypotension—Vinorelbine—lung cancer	0.000896	0.00375	CcSEcCtD
Succinylcholine—Urticaria—Topotecan—lung cancer	0.000891	0.00373	CcSEcCtD
Succinylcholine—Body temperature increased—Topotecan—lung cancer	0.000886	0.00371	CcSEcCtD
Succinylcholine—Body temperature increased—Erlotinib—lung cancer	0.000877	0.00367	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000874	0.00366	CcSEcCtD
Succinylcholine—Renal failure acute—Methotrexate—lung cancer	0.000868	0.00363	CcSEcCtD
Succinylcholine—Flushing—Etoposide—lung cancer	0.000859	0.0036	CcSEcCtD
Succinylcholine—Pulmonary oedema—Doxorubicin—lung cancer	0.000851	0.00356	CcSEcCtD
Succinylcholine—Hypersensitivity—Vinblastine—lung cancer	0.00085	0.00356	CcSEcCtD
Succinylcholine—Renal failure—Docetaxel—lung cancer	0.000843	0.00353	CcSEcCtD
Succinylcholine—Flushing—Paclitaxel—lung cancer	0.000843	0.00353	CcSEcCtD
Succinylcholine—Hypertonia—Doxorubicin—lung cancer	0.000838	0.00351	CcSEcCtD
Succinylcholine—Hypertension—Irinotecan—lung cancer	0.000837	0.0035	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Methotrexate—lung cancer	0.000828	0.00347	CcSEcCtD
Succinylcholine—Hypersensitivity—Topotecan—lung cancer	0.000826	0.00346	CcSEcCtD
Succinylcholine—Hypertension—Gemcitabine—lung cancer	0.000815	0.00341	CcSEcCtD
Succinylcholine—Arrhythmia—Paclitaxel—lung cancer	0.000811	0.00339	CcSEcCtD
Succinylcholine—Myalgia—Gemcitabine—lung cancer	0.000804	0.00336	CcSEcCtD
Succinylcholine—Anaphylactic shock—Irinotecan—lung cancer	0.000791	0.00331	CcSEcCtD
Succinylcholine—Shock—Irinotecan—lung cancer	0.000778	0.00326	CcSEcCtD
Succinylcholine—Anaphylactic shock—Gemcitabine—lung cancer	0.00077	0.00322	CcSEcCtD
Succinylcholine—Urticaria—Vinorelbine—lung cancer	0.000762	0.00319	CcSEcCtD
Succinylcholine—Body temperature increased—Vinorelbine—lung cancer	0.000758	0.00317	CcSEcCtD
Succinylcholine—Renal failure acute—Doxorubicin—lung cancer	0.000752	0.00315	CcSEcCtD
Succinylcholine—Myalgia—Cisplatin—lung cancer	0.000749	0.00313	CcSEcCtD
Succinylcholine—Hypotension—Irinotecan—lung cancer	0.000739	0.00309	CcSEcCtD
Succinylcholine—Hypotension—Gemcitabine—lung cancer	0.00072	0.00301	CcSEcCtD
Succinylcholine—Anaphylactic shock—Cisplatin—lung cancer	0.000718	0.003	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000717	0.003	CcSEcCtD
Succinylcholine—Flushing—Docetaxel—lung cancer	0.000714	0.00299	CcSEcCtD
Succinylcholine—Rash—Topotecan—lung cancer	0.000707	0.00296	CcSEcCtD
Succinylcholine—Hypersensitivity—Vinorelbine—lung cancer	0.000707	0.00296	CcSEcCtD
Succinylcholine—Dermatitis—Topotecan—lung cancer	0.000706	0.00295	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000702	0.00294	CcSEcCtD
Succinylcholine—Tachycardia—Cisplatin—lung cancer	0.000701	0.00293	CcSEcCtD
Succinylcholine—Rash—Erlotinib—lung cancer	0.000699	0.00293	CcSEcCtD
Succinylcholine—Dermatitis—Erlotinib—lung cancer	0.000699	0.00292	CcSEcCtD
Succinylcholine—Hypertension—Etoposide—lung cancer	0.000696	0.00291	CcSEcCtD
Succinylcholine—Arrhythmia—Docetaxel—lung cancer	0.000687	0.00288	CcSEcCtD
Succinylcholine—Hypertension—Paclitaxel—lung cancer	0.000682	0.00286	CcSEcCtD
Succinylcholine—Myalgia—Paclitaxel—lung cancer	0.000673	0.00282	CcSEcCtD
Succinylcholine—Hypotension—Cisplatin—lung cancer	0.000671	0.00281	CcSEcCtD
Succinylcholine—Cardiac arrest—Doxorubicin—lung cancer	0.00066	0.00276	CcSEcCtD
Succinylcholine—Anaphylactic shock—Etoposide—lung cancer	0.000658	0.00275	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000654	0.00274	CcSEcCtD
Succinylcholine—Anaphylactic shock—Paclitaxel—lung cancer	0.000645	0.0027	CcSEcCtD
Succinylcholine—Tachycardia—Etoposide—lung cancer	0.000642	0.00269	CcSEcCtD
Succinylcholine—Shock—Paclitaxel—lung cancer	0.000635	0.00266	CcSEcCtD
Succinylcholine—Tachycardia—Paclitaxel—lung cancer	0.00063	0.00263	CcSEcCtD
Succinylcholine—Body temperature increased—Irinotecan—lung cancer	0.000625	0.00262	CcSEcCtD
Succinylcholine—Hypotension—Etoposide—lung cancer	0.000615	0.00257	CcSEcCtD
Succinylcholine—Body temperature increased—Gemcitabine—lung cancer	0.000609	0.00255	CcSEcCtD
Succinylcholine—Renal failure—Methotrexate—lung cancer	0.000607	0.00254	CcSEcCtD
Succinylcholine—Rash—Vinorelbine—lung cancer	0.000605	0.00253	CcSEcCtD
Succinylcholine—Dermatitis—Vinorelbine—lung cancer	0.000604	0.00253	CcSEcCtD
Succinylcholine—Hypotension—Paclitaxel—lung cancer	0.000603	0.00252	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000588	0.00246	CcSEcCtD
Succinylcholine—Hypersensitivity—Irinotecan—lung cancer	0.000583	0.00244	CcSEcCtD
Succinylcholine—Hypertension—Docetaxel—lung cancer	0.000578	0.00242	CcSEcCtD
Succinylcholine—Myalgia—Docetaxel—lung cancer	0.00057	0.00239	CcSEcCtD
Succinylcholine—Body temperature increased—Cisplatin—lung cancer	0.000568	0.00238	CcSEcCtD
Succinylcholine—Anaphylactic shock—Docetaxel—lung cancer	0.000547	0.00229	CcSEcCtD
Succinylcholine—Shock—Docetaxel—lung cancer	0.000538	0.00225	CcSEcCtD
Succinylcholine—Tachycardia—Docetaxel—lung cancer	0.000534	0.00223	CcSEcCtD
Succinylcholine—Hypersensitivity—Cisplatin—lung cancer	0.000529	0.00221	CcSEcCtD
Succinylcholine—Renal failure—Doxorubicin—lung cancer	0.000526	0.0022	CcSEcCtD
Succinylcholine—Urticaria—Etoposide—lung cancer	0.000523	0.00219	CcSEcCtD
Succinylcholine—Body temperature increased—Etoposide—lung cancer	0.00052	0.00218	CcSEcCtD
Succinylcholine—Urticaria—Paclitaxel—lung cancer	0.000512	0.00214	CcSEcCtD
Succinylcholine—Hypotension—Docetaxel—lung cancer	0.000511	0.00214	CcSEcCtD
Succinylcholine—Body temperature increased—Paclitaxel—lung cancer	0.00051	0.00213	CcSEcCtD
Succinylcholine—Rash—Irinotecan—lung cancer	0.000499	0.00209	CcSEcCtD
Succinylcholine—Dermatitis—Irinotecan—lung cancer	0.000498	0.00208	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000498	0.00208	CcSEcCtD
Succinylcholine—Bradycardia—Doxorubicin—lung cancer	0.000489	0.00205	CcSEcCtD
Succinylcholine—Rash—Gemcitabine—lung cancer	0.000486	0.00203	CcSEcCtD
Succinylcholine—Dermatitis—Gemcitabine—lung cancer	0.000485	0.00203	CcSEcCtD
Succinylcholine—Hypersensitivity—Etoposide—lung cancer	0.000485	0.00203	CcSEcCtD
Succinylcholine—Hypersensitivity—Paclitaxel—lung cancer	0.000475	0.00199	CcSEcCtD
Succinylcholine—Rash—Cisplatin—lung cancer	0.000453	0.00189	CcSEcCtD
Succinylcholine—Dermatitis—Cisplatin—lung cancer	0.000452	0.00189	CcSEcCtD
Succinylcholine—Flushing—Doxorubicin—lung cancer	0.000446	0.00187	CcSEcCtD
Succinylcholine—Body temperature increased—Docetaxel—lung cancer	0.000432	0.00181	CcSEcCtD
Succinylcholine—Arrhythmia—Doxorubicin—lung cancer	0.000429	0.0018	CcSEcCtD
Succinylcholine—Rash—Etoposide—lung cancer	0.000415	0.00174	CcSEcCtD
Succinylcholine—Dermatitis—Etoposide—lung cancer	0.000414	0.00173	CcSEcCtD
Succinylcholine—Myalgia—Methotrexate—lung cancer	0.000411	0.00172	CcSEcCtD
Succinylcholine—Rash—Paclitaxel—lung cancer	0.000407	0.0017	CcSEcCtD
Succinylcholine—Dermatitis—Paclitaxel—lung cancer	0.000406	0.0017	CcSEcCtD
Succinylcholine—Hypersensitivity—Docetaxel—lung cancer	0.000403	0.00169	CcSEcCtD
Succinylcholine—Anaphylactic shock—Methotrexate—lung cancer	0.000394	0.00165	CcSEcCtD
Succinylcholine—Hypotension—Methotrexate—lung cancer	0.000368	0.00154	CcSEcCtD
Succinylcholine—Hypertension—Doxorubicin—lung cancer	0.000361	0.00151	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000359	0.0015	CcSEcCtD
Succinylcholine—Myalgia—Doxorubicin—lung cancer	0.000356	0.00149	CcSEcCtD
Succinylcholine—Rash—Docetaxel—lung cancer	0.000345	0.00144	CcSEcCtD
Succinylcholine—Dermatitis—Docetaxel—lung cancer	0.000344	0.00144	CcSEcCtD
Succinylcholine—Anaphylactic shock—Doxorubicin—lung cancer	0.000341	0.00143	CcSEcCtD
Succinylcholine—Shock—Doxorubicin—lung cancer	0.000336	0.0014	CcSEcCtD
Succinylcholine—Tachycardia—Doxorubicin—lung cancer	0.000333	0.00139	CcSEcCtD
Succinylcholine—Hypotension—Doxorubicin—lung cancer	0.000319	0.00133	CcSEcCtD
Succinylcholine—Urticaria—Methotrexate—lung cancer	0.000313	0.00131	CcSEcCtD
Succinylcholine—Body temperature increased—Methotrexate—lung cancer	0.000311	0.0013	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000311	0.0013	CcSEcCtD
Succinylcholine—Hypersensitivity—Methotrexate—lung cancer	0.00029	0.00121	CcSEcCtD
Succinylcholine—Urticaria—Doxorubicin—lung cancer	0.000271	0.00113	CcSEcCtD
Succinylcholine—Body temperature increased—Doxorubicin—lung cancer	0.00027	0.00113	CcSEcCtD
Succinylcholine—Hypersensitivity—Doxorubicin—lung cancer	0.000251	0.00105	CcSEcCtD
Succinylcholine—Rash—Methotrexate—lung cancer	0.000248	0.00104	CcSEcCtD
Succinylcholine—Dermatitis—Methotrexate—lung cancer	0.000248	0.00104	CcSEcCtD
Succinylcholine—Rash—Doxorubicin—lung cancer	0.000215	0.0009	CcSEcCtD
Succinylcholine—Dermatitis—Doxorubicin—lung cancer	0.000215	0.000899	CcSEcCtD
Succinylcholine—CHRM3—GPCR downstream signaling—POMC—lung cancer	2.29e-05	4.6e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—POMC—lung cancer	2.27e-05	4.56e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GSTP1—lung cancer	2.26e-05	4.54e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—JUNB—lung cancer	2.26e-05	4.54e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—JUNB—lung cancer	2.25e-05	4.52e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—JUNB—lung cancer	2.23e-05	4.48e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CAT—lung cancer	2.2e-05	4.42e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—APOA1—lung cancer	2.2e-05	4.42e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CG—lung cancer	2.19e-05	4.4e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CG—lung cancer	2.18e-05	4.39e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CG—lung cancer	2.16e-05	4.35e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ABCB1—lung cancer	2.14e-05	4.3e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CD—lung cancer	2.12e-05	4.26e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CD—lung cancer	2.11e-05	4.25e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.1e-05	4.23e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—TYMS—lung cancer	2.1e-05	4.22e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CD—lung cancer	2.09e-05	4.21e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—POMC—lung cancer	2.09e-05	4.19e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—POMC—lung cancer	2.08e-05	4.18e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GSTM1—lung cancer	2.08e-05	4.18e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—POMC—lung cancer	2.06e-05	4.14e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—STK11—lung cancer	2.05e-05	4.12e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—STK11—lung cancer	2.04e-05	4.11e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6R—lung cancer	2.03e-05	4.09e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6R—lung cancer	2.03e-05	4.08e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—STK11—lung cancer	2.02e-05	4.07e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6R—lung cancer	2.01e-05	4.04e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CG—lung cancer	2.01e-05	4.03e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FOXO3—lung cancer	1.98e-05	3.98e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FOXO3—lung cancer	1.97e-05	3.96e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CYP1A1—lung cancer	1.97e-05	3.96e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ERCC2—lung cancer	1.95e-05	3.93e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FOXO3—lung cancer	1.95e-05	3.92e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—MAP2K1—lung cancer	1.94e-05	3.9e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—MAP2K1—lung cancer	1.93e-05	3.88e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CD—lung cancer	1.93e-05	3.87e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CD—lung cancer	1.92e-05	3.86e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	1.91e-05	3.85e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—POMC—lung cancer	1.91e-05	3.84e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	1.9e-05	3.82e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CREBBP—lung cancer	1.86e-05	3.74e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AVP—lung cancer	1.85e-05	3.73e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CB—lung cancer	1.85e-05	3.71e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AVP—lung cancer	1.85e-05	3.71e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CB—lung cancer	1.84e-05	3.7e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AVP—lung cancer	1.83e-05	3.68e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	1.82e-05	3.67e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF1R—lung cancer	1.78e-05	3.59e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF1R—lung cancer	1.78e-05	3.57e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CXCL8—lung cancer	1.78e-05	3.57e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CXCL8—lung cancer	1.77e-05	3.56e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CD—lung cancer	1.76e-05	3.54e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF1R—lung cancer	1.76e-05	3.54e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	1.75e-05	3.52e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HES1—lung cancer	1.75e-05	3.52e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HES1—lung cancer	1.75e-05	3.51e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ALB—lung cancer	1.74e-05	3.5e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HES1—lung cancer	1.73e-05	3.48e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—RAF1—lung cancer	1.72e-05	3.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—RAF1—lung cancer	1.71e-05	3.44e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—IL2—lung cancer	1.7e-05	3.41e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—RAF1—lung cancer	1.7e-05	3.41e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—IL2—lung cancer	1.69e-05	3.4e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOA1—lung cancer	1.69e-05	3.4e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CB—lung cancer	1.68e-05	3.37e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—IL2—lung cancer	1.68e-05	3.37e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CB—lung cancer	1.67e-05	3.36e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	1.66e-05	3.33e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CXCL8—lung cancer	1.61e-05	3.24e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CXCL8—lung cancer	1.61e-05	3.23e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ERBB3—lung cancer	1.6e-05	3.22e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ERBB3—lung cancer	1.6e-05	3.21e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CXCL8—lung cancer	1.59e-05	3.2e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ERBB3—lung cancer	1.58e-05	3.18e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CG—lung cancer	1.54e-05	3.1e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL2—lung cancer	1.54e-05	3.1e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CB—lung cancer	1.54e-05	3.09e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL2—lung cancer	1.54e-05	3.09e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TERT—lung cancer	1.54e-05	3.09e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TERT—lung cancer	1.53e-05	3.08e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTGS2—lung cancer	1.52e-05	3.06e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL2—lung cancer	1.52e-05	3.06e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TERT—lung cancer	1.52e-05	3.05e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FGFR1—lung cancer	1.49e-05	3e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FGFR1—lung cancer	1.49e-05	2.99e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FGFR1—lung cancer	1.47e-05	2.96e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HIF1A—lung cancer	1.47e-05	2.95e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—POMC—lung cancer	1.47e-05	2.95e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HIF1A—lung cancer	1.46e-05	2.94e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HIF1A—lung cancer	1.45e-05	2.91e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CREBBP—lung cancer	1.43e-05	2.87e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOA1—lung cancer	1.42e-05	2.85e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOA1—lung cancer	1.41e-05	2.84e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KDR—lung cancer	1.4e-05	2.82e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KDR—lung cancer	1.4e-05	2.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOA1—lung cancer	1.4e-05	2.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KDR—lung cancer	1.39e-05	2.79e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CD—lung cancer	1.36e-05	2.73e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ALB—lung cancer	1.34e-05	2.69e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTEN—lung cancer	1.33e-05	2.67e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KIT—lung cancer	1.29e-05	2.6e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APC—lung cancer	1.29e-05	2.6e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CG—lung cancer	1.29e-05	2.6e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—NRAS—lung cancer	1.29e-05	2.6e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KIT—lung cancer	1.29e-05	2.59e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CG—lung cancer	1.29e-05	2.59e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APC—lung cancer	1.29e-05	2.59e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—NRAS—lung cancer	1.29e-05	2.59e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EGF—lung cancer	1.28e-05	2.57e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CG—lung cancer	1.28e-05	2.57e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APC—lung cancer	1.28e-05	2.57e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KIT—lung cancer	1.28e-05	2.57e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—NRAS—lung cancer	1.28e-05	2.57e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EGF—lung cancer	1.28e-05	2.56e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—EP300—lung cancer	1.27e-05	2.55e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EGF—lung cancer	1.26e-05	2.54e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—MAPK3—lung cancer	1.24e-05	2.49e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—MAPK3—lung cancer	1.24e-05	2.48e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—POMC—lung cancer	1.23e-05	2.48e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—POMC—lung cancer	1.23e-05	2.47e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—MAPK3—lung cancer	1.22e-05	2.46e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—BRAF—lung cancer	1.22e-05	2.44e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—POMC—lung cancer	1.22e-05	2.44e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—BRAF—lung cancer	1.21e-05	2.44e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6R—lung cancer	1.2e-05	2.42e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—BRAF—lung cancer	1.2e-05	2.41e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CREBBP—lung cancer	1.2e-05	2.41e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6R—lung cancer	1.2e-05	2.41e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CREBBP—lung cancer	1.2e-05	2.4e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6R—lung cancer	1.19e-05	2.38e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CREBBP—lung cancer	1.18e-05	2.38e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CB—lung cancer	1.18e-05	2.38e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—EGFR—lung cancer	1.18e-05	2.37e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—EGFR—lung cancer	1.18e-05	2.36e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTGS2—lung cancer	1.17e-05	2.35e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—EGFR—lung cancer	1.16e-05	2.34e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAP2K1—lung cancer	1.15e-05	2.3e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAP2K1—lung cancer	1.14e-05	2.29e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CD—lung cancer	1.14e-05	2.29e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CD—lung cancer	1.13e-05	2.28e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAP2K1—lung cancer	1.13e-05	2.27e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	1.13e-05	2.26e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	1.12e-05	2.26e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CD—lung cancer	1.12e-05	2.26e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—KRAS—lung cancer	1.11e-05	2.24e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	1.11e-05	2.24e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—KRAS—lung cancer	1.11e-05	2.23e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—KRAS—lung cancer	1.1e-05	2.21e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	1.02e-05	2.06e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTEN—lung cancer	1.02e-05	2.05e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	1.02e-05	2.05e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MDM2—lung cancer	1.02e-05	2.05e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MDM2—lung cancer	1.02e-05	2.04e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—RAF1—lung cancer	1.02e-05	2.04e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—RAF1—lung cancer	1.01e-05	2.03e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.01e-05	2.03e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MDM2—lung cancer	1.01e-05	2.02e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ERBB2—lung cancer	1e-05	2.02e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—RAF1—lung cancer	1e-05	2.01e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ERBB2—lung cancer	1e-05	2.01e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ERBB2—lung cancer	9.92e-06	1.99e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MTOR—lung cancer	9.92e-06	1.99e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CB—lung cancer	9.92e-06	1.99e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CB—lung cancer	9.89e-06	1.99e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MTOR—lung cancer	9.89e-06	1.99e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CB—lung cancer	9.79e-06	1.97e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MTOR—lung cancer	9.79e-06	1.97e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—EP300—lung cancer	9.74e-06	1.96e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CXCL8—lung cancer	9.53e-06	1.92e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CXCL8—lung cancer	9.5e-06	1.91e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—HRAS—lung cancer	9.47e-06	1.9e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—HRAS—lung cancer	9.44e-06	1.9e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CXCL8—lung cancer	9.41e-06	1.89e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CA—lung cancer	9.37e-06	1.88e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—HRAS—lung cancer	9.35e-06	1.88e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AKT1—lung cancer	9.21e-06	1.85e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AKT1—lung cancer	9.18e-06	1.84e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CASP3—lung cancer	9.12e-06	1.83e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL2—lung cancer	9.11e-06	1.83e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CASP3—lung cancer	9.09e-06	1.83e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT1—lung cancer	9.09e-06	1.83e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL2—lung cancer	9.08e-06	1.82e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6—lung cancer	9.06e-06	1.82e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6—lung cancer	9.03e-06	1.82e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CASP3—lung cancer	9e-06	1.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL2—lung cancer	8.99e-06	1.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6—lung cancer	8.95e-06	1.8e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCND1—lung cancer	8.88e-06	1.78e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—JUN—lung cancer	8.86e-06	1.78e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCND1—lung cancer	8.85e-06	1.78e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—JUN—lung cancer	8.83e-06	1.77e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCND1—lung cancer	8.76e-06	1.76e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—JUN—lung cancer	8.75e-06	1.76e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MMP9—lung cancer	8.62e-06	1.73e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MMP9—lung cancer	8.59e-06	1.73e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CDKN1A—lung cancer	8.59e-06	1.73e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PTEN—lung cancer	8.57e-06	1.72e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CDKN1A—lung cancer	8.56e-06	1.72e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PTEN—lung cancer	8.54e-06	1.72e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MMP9—lung cancer	8.51e-06	1.71e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	8.48e-06	1.7e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PTEN—lung cancer	8.46e-06	1.7e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT1—lung cancer	8.36e-06	1.68e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT1—lung cancer	8.33e-06	1.67e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT1—lung cancer	8.25e-06	1.66e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EP300—lung cancer	8.17e-06	1.64e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EP300—lung cancer	8.15e-06	1.64e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EP300—lung cancer	8.07e-06	1.62e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SRC—lung cancer	7.95e-06	1.6e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SRC—lung cancer	7.92e-06	1.59e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SRC—lung cancer	7.85e-06	1.58e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—VEGFA—lung cancer	7.74e-06	1.56e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—VEGFA—lung cancer	7.72e-06	1.55e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—STAT3—lung cancer	7.66e-06	1.54e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AKT1—lung cancer	7.66e-06	1.54e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NRAS—lung cancer	7.65e-06	1.54e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—VEGFA—lung cancer	7.64e-06	1.54e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—STAT3—lung cancer	7.64e-06	1.54e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NRAS—lung cancer	7.62e-06	1.53e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—STAT3—lung cancer	7.57e-06	1.52e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NRAS—lung cancer	7.55e-06	1.52e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK3—lung cancer	7.32e-06	1.47e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK3—lung cancer	7.3e-06	1.47e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK3—lung cancer	7.23e-06	1.45e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CA—lung cancer	7.21e-06	1.45e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MYC—lung cancer	7.12e-06	1.43e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MYC—lung cancer	7.1e-06	1.43e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MYC—lung cancer	7.03e-06	1.41e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EGFR—lung cancer	6.97e-06	1.4e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EGFR—lung cancer	6.94e-06	1.4e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EGFR—lung cancer	6.88e-06	1.38e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KRAS—lung cancer	6.58e-06	1.32e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KRAS—lung cancer	6.56e-06	1.32e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KRAS—lung cancer	6.5e-06	1.31e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CA—lung cancer	6.05e-06	1.21e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CA—lung cancer	6.03e-06	1.21e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	5.97e-06	1.2e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AKT1—lung cancer	5.89e-06	1.18e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TP53—lung cancer	5.85e-06	1.18e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TP53—lung cancer	5.83e-06	1.17e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TP53—lung cancer	5.77e-06	1.16e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HRAS—lung cancer	5.59e-06	1.12e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HRAS—lung cancer	5.58e-06	1.12e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HRAS—lung cancer	5.52e-06	1.11e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6—lung cancer	5.35e-06	1.08e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6—lung cancer	5.34e-06	1.07e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6—lung cancer	5.28e-06	1.06e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT1—lung cancer	4.94e-06	9.92e-06	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT1—lung cancer	4.92e-06	9.89e-06	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT1—lung cancer	4.88e-06	9.8e-06	CbGpPWpGaD
